ICBio-Initiative
An Indian full-service CRO providing cost-effective, end-to-end clinical research solutions, including BA/BE studies and bioanalytical services, for global pharma and biotech clients.
Private Company
Funding information not available
AI Company Overview
An Indian full-service CRO providing cost-effective, end-to-end clinical research solutions, including BA/BE studies and bioanalytical services, for global pharma and biotech clients.
Technology Platform
Integrated clinical and bioanalytical service platform featuring state-of-the-art LC-MS/MS and ICP-MS instrumentation, a 100+ bed clinical unit, and a NABL-accredited central laboratory for end-to-end clinical research support.
Opportunities
Risk Factors
Competitive Landscape
Competes with other Indian CROs (e.g., Syngene, Lambda Therapeutic) and global CROs on cost and quality; differentiates through a strong track record in BA/BE studies, multiple international regulatory approvals, and an integrated, in-house clinical and bioanalytical infrastructure.